Poseida Therapeutics Inc. (PSTX)
NASDAQ: PSTX
· Real-Time Price · USD
9.50
0.00 (0.00%)
At close: Jan 07, 2025, 10:00 PM
Poseida Therapeutics Revenue Breakdown
| Period Ending | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Collaboration Revenue Revenue | 71.75M | 25.97M | 28.14M | 34.35M | 9.35M | 20.01M | 10.34M | 10.05M | 116.31M | 2.7M | 1.44M |
| Collaboration Revenue Revenue Growth | +176.24% | -7.71% | -18.07% | +267.27% | -53.27% | +93.49% | +2.91% | -91.36% | +4207.63% | +88.15% | n/a |
Revenue by Geography
| Period Ending | Dec 31, 2012 |
|---|---|
| United States Revenue | 17.59M |
| United States Revenue Growth | n/a |
Operating Expense Breakdown
| Period Ending | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Dec 31, 2017 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selling, General, and Administrative Revenue | 10.09M | 12.18M | 9.8M | 8.86M | 8.09M | 8.68M | 11.81M | 9.37M | 9.39M | 9.24M | 9.55M | 9.61K | 9.07M | 8.87M | 8.37M | 7.48K | 6.46M | 4.24M | 4.85M | 4.01M | 4.01M | 4.04M | 6.4M | 2.4M | 1.59M |
| Selling, General, and Administrative Revenue Growth | -17.16% | +24.33% | +10.59% | +9.49% | -6.73% | -26.52% | +26.04% | -0.22% | +1.65% | -3.24% | +99244.36% | -99.89% | +2.20% | +6.00% | +111844.89% | -99.88% | +52.46% | -12.73% | +21.11% | +0.02% | -0.87% | -36.83% | +166.96% | +50.28% | n/a |
| Research and Development Revenue | 41.91M | 44.2M | 41.54M | 42.05M | 37.48M | 39.19M | 38.05M | 33.9M | 35.14M | 35.01M | 48.85M | 39.11K | 32.52M | 36.01M | 29.09M | 27.88K | 27.02M | 25.21M | 23.41M | 19.2M | 15.7M | 16.88M | 8.61M | 9.75M | 4.35M |
| Research and Development Revenue Growth | -5.17% | +6.40% | -1.20% | +12.18% | -4.36% | +3.00% | +12.23% | -3.51% | +0.37% | -28.34% | +124813.70% | -99.88% | -9.68% | +23.76% | +104242.99% | -99.90% | +7.16% | +7.67% | +21.92% | +22.35% | -7.02% | +95.99% | -11.69% | +124.00% | n/a |